West Pharma CEO Michel Lagarde files initial beneficial ownership statement
WST•Initial Form 3 filing reports CEO shareholding
- West Pharmaceutical Services President and CEO Michel Lagarde reported 7,850 shares of common stock in an initial Form 3 filing.




